Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT04487691
What this trial is testing

Nebulized PL for Post-COVID-19 Syndrome

Who this might be right for
Covid19
Regenexx, LLC 1
Large-scale testing (Phase 3)Study completedNCT00475410
What this trial is testing

Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease

Who this might be right for
Anal Fistula
Tigenix S.A.U. 214
Testing effectiveness (Phase 2)Study completedNCT01045460
What this trial is testing

Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Testing effectiveness (Phase 2)Study completedNCT03981549
What this trial is testing

Treatment of Central Retinal Vein Occlusion Using Stem Cells Study

Who this might be right for
Central Retinal Vein Occlusion
The Emmes Company, LLC 16
Early research (Phase 1)Study completedNCT00477815
What this trial is testing

Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 30
Testing effectiveness (Phase 2)Study completedNCT05154591
What this trial is testing

CKDu Treated With Intra-arterial Infusion of Autologous SVF Cells

Who this might be right for
Chronic Renal Failure of Unknown Cause
Samuel Vilchez, PhD 18
Testing effectiveness (Phase 2)Study completedNCT01351610
What this trial is testing

Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia

Who this might be right for
Critical Limb IschemiaPeripheral Artery Disease
Apceth GmbH & Co. KG 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT06823713
What this trial is testing

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

Who this might be right for
End-stage Liver Disease (ESLD)Cirrhosis, LiverCirrhosis, Decompensated+5 more
Resolution Therapeutics Limited 30
Testing effectiveness (Phase 2)Study completedNCT01690143
What this trial is testing

Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
University of Alabama at Birmingham 45
Early research (Phase 1)Active Not RecruitingNCT04049513
What this trial is testing

ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)

Who this might be right for
Lymphomas Non-Hodgkin's B-CellDiffuse Large B-cell Lymphoma (DLBCL)Primary Mediastinal B-cell Lymphoma (PMBCL)+3 more
Malaghan Institute of Medical Research 30
Early research (Phase 1)Ended earlyNCT00040651
What this trial is testing

Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients

Who this might be right for
SclerodermaSystemic Sclerosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Testing effectiveness (Phase 2)WithdrawnNCT01453829
What this trial is testing

Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke

Who this might be right for
Stroke
Ageless Regenerative Institute
Not applicableEnded earlyNCT06924853
What this trial is testing

Platelet Lysate vs Saline for Lumbosacral Radiculopathy

Who this might be right for
Lumbosacral RadiculopathyLumbar Radiculopathy
Regenexx, LLC 2
Not applicableLooking for participantsNCT06245629
What this trial is testing

Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

Who this might be right for
Myeloma Multiple
Uppsala University 100
Early research (Phase 1)Ended earlyNCT01312376
What this trial is testing

Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer

Who this might be right for
Ovarian CarcinomaFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 18
Not applicableWithdrawnNCT04858152
What this trial is testing

Hair Transplantation for Treatment of Vitiligo

Who this might be right for
Vitiligo
Mehdi Rashighi
Testing effectiveness (Phase 2)Ended earlyNCT01239368
What this trial is testing

Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Myeloma, Plasma-CellMyeloma-MultipleMyelomatosis
National Cancer Institute (NCI) 34
Not applicableLooking for participantsNCT05400590
What this trial is testing

Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients

Who this might be right for
Aniridia
Fondation Ophtalmologique Adolphe de Rothschild 24
Testing effectiveness (Phase 2)Study completedNCT00586014
What this trial is testing

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Duke University 91
Testing effectiveness (Phase 2)UnknownNCT05962333
What this trial is testing

Effect and Safety MABs Administration m.3243A>G Mutation Carriers

Who this might be right for
Mitochondrial Myopathies
Maastricht University 20
Next Page